Veradermics (MANE) Shares Outstanding (Weighted Average) (2024 - 2026)

Veradermics has reported Shares Outstanding (Weighted Average) for 3 years, with the latest figure at $22.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 2980.89% year-over-year to $22.7 million; the trailing twelve-month figure through Mar 2026 stood at $22.7 million (up 2980.89% YoY), and the FY2025 full-year result was $744991.0, up 1.09% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $22.7 million, up from $744991.0 in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $22.7 million in Q1 2026, with the low at $736933.0 in Q4 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $6.2 million across 3 years, with a median of $740962.0 in 2024.
• Annual changes were most pronounced in 2025 — Shares Outstanding (Weighted Average) climbed 1.09% — and 2026, when it surged 2980.89%.
• Veradermics' Shares Outstanding (Weighted Average) stood at $736933.0 in 2024, then increased by 1.09% to $744991.0 in 2025, then surged by 2947.57% to $22.7 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $22.7 million (Q1 2026), $744991.0 (Q4 2025), and $736933.0 (Q1 2025), per Business Quant data.